SCHEMBL18601922

SCHEMBL18601922

CC(C)(C)CC(=O)c1ccccc1N1CN(c2ccccc2)C2(CCNCC2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1L1 Q9UHC9 7/20 0.42
HSD17B10 Q99714 1/20 0.41
BDKRB2 P30411 1/20 0.40
DDR1 Q08345 3/20 0.37
DRD2 P14416 3/20 0.37
DRD4 P21917 3/20 0.37
DRD3 P35462 3/20 0.37
HTR2A P28223 1/20 0.37
OPRM1 P35372 3/20 0.36
OPRD1 P41143 3/20 0.36
OPRK1 P41145 3/20 0.36
OPRL1 P41146 3/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL319455 0.84 HSD17B10 (0.42) NPC1L1HSD17B10BDKRB2DDR1OPRM1
SCHEMBL9998864 0.79 HSD17B10 (0.43) NPC1L1HSD17B10BDKRB2DDR1OPRM1
SCHEMBL20187016 0.77 HSD17B10 (0.57) NPC1L1HSD17B10BDKRB2DDR1OPRM1
SCHEMBL20187107 0.76 DDR1 (0.53) NPC1L1HSD17B10BDKRB2DDR1DRD2
SCHEMBL20187117 0.73 DDR1 (0.58) NPC1L1HSD17B10BDKRB2DDR1DRD2
SCHEMBL3067132 0.73 OPRL1 (0.61) NPC1L1HSD17B10BDKRB2DRD2DRD4
Trifluoroacetic Acid SCHEMBL6247355 0.72 OPRM1 (0.52) NPC1L1HSD17B10BDKRB2DRD2DRD4
Hydrochloric Acid SCHEMBL3231229 0.72 OPRL1 (0.60) NPC1L1HSD17B10BDKRB2DRD2DRD4
Hydrochloric Acid SCHEMBL9485290 0.72 OPRL1 (0.60) NPC1L1HSD17B10BDKRB2DRD2DRD4
SCHEMBL319018 0.72 DDR1 (0.49) NPC1L1HSD17B10BDKRB2DDR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138841-A1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE Altos Therapeutics, LLC (US) 2017-03-08 EP disclosed